Search for: "SHEPPARD v. STATE" Results 381 - 400 of 414
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Feb 2016, 7:18 am by Podhurst Orseck
The high court in in 2012 dismissed as “improvidently granted review” First American v. [read post]
8 Sep 2022, 3:34 pm by Gregory Schick
  The Final Rules state that the Pay Versus Performance Disclosure will not be deemed to be incorporated by reference into any filing under either the Securities Act of 1933 or the Securities Exchange Act of 1934 (the “Exchange Act”) except to the extent that the issuer affirmatively does incorporate it by reference. [read post]
8 Nov 2010, 10:57 am by Roshonda Scipio
. : Columbia University Press, c2010.Constitutional LawKF228.G528 J64 2010Gibbons v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
21 Sep 2020, 12:55 pm by Eric Raphan and Jamie Moelis*
Specifically, the Revised Final Rule does the following: (i) reaffirms the “work-availability” requirement; (ii) reaffirms employer consent for taking FFCRA leave intermittently; (iii) revises the definition of “healthcare provider”; (iv) clarifies that employees must provide required documentation supporting their need for FFCRA leave to their employers as soon as practicable; and (v) corrects an inconsistency regarding when employees may be required to provide… [read post]
16 Jan 2014, 4:30 am by Guest Blogger
Professor Tony Sheppard of the Faculty of Law at the University of British Columbia, was “a member of the Task Force research team and principal writer of the Report. [read post]